| Gene symbol | RLBP1 | Synonyms | CRALBP | Type of gene | protein-coding |
| Chromosome | 15 | Map location | 15q26.1 | dbXrefs | |
| Description | retinaldehyde binding protein 1 | ||||
| GTO ID | GTC1835 |
| Trial ID | NCT03374657 |
| Disease | Retinitis Pigmentosa |
| Altered gene | RLBP1 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | CPK850 |
| Phase | Phase1|Phase2 |
| Recruitment status | Active, Not Recruiting |
| Title | An Open-label First-in-human Single Ascending Dose Study to Explore Safety, Tolerability and Efficacy of Subretinal Administration of CPK850 Gene Therapy in Patients With Retinitis Pigmentosa Due to Mutations in the Retinaldehyde Binding Protein 1 (RLBP1) Gene |
| Year | 2017 |
| Country | Sweden |
| Company sponsor | Novartis Pharmaceuticals |
| Other ID(s) | CCPK850X2202|2016-002696-10 |
| Vector information | |||||||||||
|
|||||||||||
| Cohort 1 | |||||||
|
|||||||